Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1405-1413

  Moore, P ^a   Kyne, L ^a,b   Martin, A ^b   Solomon, K ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; TAUROCHOLIC ACID; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE SEVERITY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RIBOTYPING; SPORE GERMINATION; TREATMENT FAILURE; TREATMENT RESPONSE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CULTURE MEDIA; HUMANS; RECURRENCE; RIBOTYPING; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY; SPORES, BACTERIAL; TAUROCHOLIC ACID; TREATMENT FAILURE;

EID: 84881603904     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.056614-0     Document Type: Article

References (34)

1. Baines, S. D., O'Connor, R., Saxton, K., Freeman, J. & Wilcox, M. H. (2009). Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. J Antimicrob Chemother 63, 520-525.
2. Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B. & Petit, J. C. (2000). Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2386-2388.
3. Burns, D. A., Heap, J. T. & Minton, N. P. (2010a). The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16, 618-622.
4. Burns, D. A., Heap, J. T. & Minton, N. P. (2010b). SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. J Bacteriol 192, 657-664.
5. Burns, K., Skally, M., Solomon, K., Scott, L., McDermott, S., O'Flanagan, D., Fanning, S., Kyne, L., Fenelon, L. & Fitzpatrick, F. (2010c). Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009. Infect Control Hosp Epidemiol 31, 1085-1087.
6. CLSI (2007). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria Approved Standard M11-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Cohen, S. H., Tang, Y. J. & Silva, J., Jr (2000). Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 181, 659-663.
8. Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., Wilcox, M. H., Society for Healthcare Epidemiology of America & Infectious Diseases Society of America (2010). Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31, 431-455.
9. Freeman, J., Baines, S. D., Jabes, D. & Wilcox, M. H. (2005). Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection. J Antimicrob Chemother 56, 717-725.
10. Freeman, J., Baines, S. D., Saxton, K. & Wilcox, M. H. (2007). Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. J Antimicrob Chemother 60, 83-91.
11. Gerding, D. N., Muto, C. A. & Owens, R. C., Jr (2008). Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46 (Suppl 1), S43-S49.
12. Heeg, D., Burns, D. A., Cartman, S. T. & Minton, N. P. (2012). Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PLoS ONE 7, e32381.
13. Howerton, A., Ramirez, N. & Abel-Santos, E. (2011). Mapping interactions between germinants and Clostridium difficile spores. J Bacteriol 193, 274-282.
14. Hu, M. Y., Maroo, S., Kyne, L., Cloud, J., Tummala, S., Katchar, K., Dreisbach, V., Noddin, L. & Kelly, C. P. (2008). A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. Clin Gastroenterol Hepatol 6, 1354-1360.
15. Kelly, C. P., Pothoulakis, C. & LaMont, J. T. (1994). Clostridium difficile colitis. N Engl J Med 330, 257-262.
16. Kyne, L., Warny, M., Qamar, A. & Kelly, C. P. (2001). Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357, 189-193.
17. McFarland, L. V., Elmer, G. W. & Surawicz, C. M. (2002). Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97, 1769-1775.
18. Norén, T., Akerlund, T., Bäck, E., Sjöberg, L., Persson, I., Alriksson, I. & Burman, L. G. (2004). Molecular epidemiology of hospitalassociated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42, 3635-3643.
19. Oka, K., Osaki, T., Hanawa, T., Kurata, S., Okazaki, M., Manzoku, T., Takahashi, M., Tanaka, M., Taguchi, H. &other authors (2012). Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J ClinMicrobiol 50, 915-921.
20. Paidhungat, M. & Setlow, P. (2000). Role of ger proteins in nutrient and nonnutrient triggering of spore germination in Bacillus subtilis. J Bacteriol 182, 2513-2519.
21. Paredes-Sabja, D., Bond, C., Carman, R. J., Setlow, P. & Sarker, M. R. (2008). Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficileassociated disease (CDAD). Microbiology 154, 2241-2250.
22. Paredes-Sabja, D., Setlow, P. & Sarker, M. R. (2009). Role of gerKB in germination and outgrowth of Clostridium perfringens spores. Appl Environ Microbiol 75, 3813-3817.
23. Ramirez, N., Liggins, M. & Abel-Santos, E. (2010). Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores. J Bacteriol 192, 4215-4222.
24. Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. & Donskey, C. J. (2007). Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45, 992-998.
25. Rupnik, M., Avesani, V., Janc, M., von Eichel-Streiber, C. & Delmée, M. (1998). A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240-2247.
26. Setlow, P. (2003). Spore germination. Curr Opin Microbiol 6, 550-556.
27. Solomon, K., Murray, S., Scott, L., McDermott, S., Drudy, D., Martin, A., O'Donoghue, C., Skally, M., Burns, K. & other authors (2011). An investigation of the subtype diversity of clinical isolates of Irish Clostridium difficile ribotypes 027 and 078 by repetitive-extragenic palindromic PCR. J Med Microbiol 60, 1080-1087.
28. Sorg, J. A. & Sonenshein, A. L. (2008). Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190, 2505-2512.
29. Sorg, J. A. & Sonenshein, A. L. (2009). Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol 191, 1115-1117.
30. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
31. Voth, D. E. & Ballard, J. D. (2005). Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18, 247-263.
32. Warren, C. A., Opstal, E. J., Riggins, M. S., Li, Y., Moore, J. H., Kolling, G. L., Guerrant, R. L. & Hoffman, P. S. (2012). Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother 57, 689-696.
33. Wilcox, M. H., Fawley, W. N., Settle, C. D. & Davidson, A. (1998). Recurrence of symptoms in Clostridium difficile infection-relapse or reinfection? J Hosp Infect 38, 93-100.
34. Wilson, K. H. (1983). Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 18, 1017-1019.